Disease and Age-Associated Targets Predicted Using AI Discovery Engine
Alex Zhavoronkov, PhD, who is the founder and CEO of Insilico Medicine is a pioneer in generative AI for drug discovery and in revealing dual pathways for aging and disease, will present at The Fourth Summit.
Source: azorobotics.com